Long-Term Trends in Breast Cancer Tumor Profiles & Disparities

乳腺癌肿瘤概况的长期趋势

基本信息

  • 批准号:
    8636410
  • 负责人:
  • 金额:
    $ 17.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-01 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our proposed exploratory study focuses on a significant problem: the absence of data on long-term trends in breast cancer tumor profiles, overall and in relation to race/ethnicity and socioeconomic position. The value of such long-term data is that they can uniquely reveal what aspects of tumor biology are amenable to change. Relevant examples include: (1) the long-term rise and recent fall of breast cancer incidence, following sharp decreases of hormone therapy use after publication of the Women's Health Initiative results in 2002, with US declines varying by estrogen receptor (ER) status, socioeconomic position and race/ethnicity, and (2) our new study documenting that between 1992 and 2005, the US white/black odds ratio for ER+ tumors among breast cancer cases likewise rose and fell. These findings, along with new work on the epigenetic regulation of breast tumor evolution and biomarkers, suggest that: (a) the biological expression and social patterning of breast cancer, far from being fixed, can change, and (b) analyzing data on long-term trends has important implications for both understanding the causes of and reducing racial/ethnic and socioeconomic disparities in breast cancer incidence, survival, and mortality. In this R21, we accordingly propose to assess the feasibility of conducting an R01 on long-term trends in breast cancer tumor profiles, overall and by race/ethnicity and socioeconomic position, by determining: (1) if current biomarker assays can be used on tumor specimens extending back to the 1940s, and (2) if, in the selected study population, the proportion of cases for whom we can locate both tumor blocks and medical charts is sufficient for the envisioned R01. The source of the breast tumor specimens will be the United States (US) and New Zealand (NZ), two countries with uniquely long-term cancer registry data and well- documented racial/ethnic and socioeconomic disparities in breast cancer incidence, survival, and mortality. Our Specific Aims accordingly are: Aim 1: Determine the feasibility of locating breast cancer patients' tumor specimens and medical charts, spanning from the 1940s to 2010, from: (a) Kaiser Permanente (KP) Division of Research (Oakland, CA), whose tumor records and patient database extends back to 1947, and (b) The New Zealand Cancer Registry, established in 1948; Aim 2: Determine whether current assays for breast cancer biomarkers can validly be employed with specimens dating back to the 1940s, as obtained from Kaiser Permanente (1947-2010); Aim 3: Determine if results for Aims 1 and 2 support the feasibility of developing an R01 to study long-term trends in prevalence of - and racial/ethnic and socio- economic disparities in - breast cancer tumor profiles (using the KP and NZ data); and Aim 4: Disseminate results by publishing scientific manuscripts and, if warranted, use results to prepare an R01 to conduct the first long-term and cross-country (US and NZ) analysis of trends in breast cancer tumor profiles and racial/ ethnic and socioeconomic disparities in these biomarkers, with major implications for prevention and treatment.
描述(由申请人提供):我们提出的探索性研究重点是一个重大问题:缺少有关乳腺癌肿瘤概况的长期趋势的数据,整体以及与种族/种族和社会经济地位有关。这种长期数据的价值在于,它们可以独特地揭示肿瘤生物学的哪些方面可以改变。 Relevant examples include: (1) the long-term rise and recent fall of breast cancer incidence, following sharp decreases of hormone therapy use after publication of the Women's Health Initiative results in 2002, with US declines varying by estrogen receptor (ER) status, socioeconomic position and race/ethnicity, and (2) our new study documenting that between 1992 and 2005, the US white/black odds ratio for ER+ tumors among breast cancer cases likewise玫瑰倒下。这些发现,以及有关乳腺肿瘤进化和生物标志物的表观遗传调节的新工作,表明:(a)乳腺癌的生物表达和社会形态,远非固定,可以改变,并且(b)对长期趋势进行分析具有重要的意义,使人们对理解种族/种族/种族/种族和社会经济性疾病的疾病和越来越多的疾病,并在乳腺癌中降低了乳腺癌的疾病,并保持了乳腺癌的疾病,并保持了癌症,并保持了癌症的疾病。 在此R21中,我们因此提议评估R01对乳腺癌肿瘤谱的长期趋势的可行性,整体和种族/族裔和社会经济位置,通过确定:(1)当前的生物标志物测定可以使用当前的生物标志物在肿瘤的肿瘤标本中使用,并在1940年代进行的肿瘤中使用该肿瘤,以及(2),如果该肿瘤的范围是(2),那么(2)的肿瘤(2),我们的肿瘤范围(2),我们的肿瘤可能会在所选的anmor中,以及(2),我们的肿瘤可能会在所选的范围内(我们的肿瘤范围)进行了分配,那么我们的肿瘤标本可以使用。对于设想的R01,图表就足够了。乳腺肿瘤标本的来源将是美国(美国)和新西兰(NZ),这是两个具有独特的长期癌症注册表数据的国家,以及据此记录的种族/种族和社会经济差异,在乳腺癌发病率,生存和死亡率中。 Our Specific Aims accordingly are: Aim 1: Determine the feasibility of locating breast cancer patients' tumor specimens and medical charts, spanning from the 1940s to 2010, from: (a) Kaiser Permanente (KP) Division of Research (Oakland, CA), whose tumor records and patient database extends back to 1947, and (b) The New Zealand Cancer Registry, established in 1948; AIM 2:确定当前的乳腺癌生物标志物的测定是否可以通过可追溯到1940年代的标本有效地使用,如Kaiser Permanente(1947-2010)所获得的那样;目标3:确定目标1和2的结果是否支持开发R01来研究 - 乳腺癌肿瘤谱的长期趋势的可行性,以及种族/种族和社会经济差异(使用KP和NZ数据);目标4:通过发表科学手稿来传播结果,如果有必要,则使用结果来准备R01,以对乳腺癌肿瘤特征以及这些生物标志物中的种族/族裔和社会经济差异的趋势进行第一长期和越野(US和NZ)分析,对这些生物标志物进行了主要影响,并对预防和治疗产生了重大影响。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009).
  • DOI:
    10.1038/npjbcancer.2015.16
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    Krieger N;Habel LA;Waterman PD;Shabani M;Ellison-Loschmann L;Achacoso NS;Acton L;Schnitt SJ
  • 通讯作者:
    Schnitt SJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NANCY KRIEGER其他文献

NANCY KRIEGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NANCY KRIEGER', 18)}}的其他基金

Advancing novel methods to measure and analyze multiple types of discrimination for population health research
为人口健康研究推进测量和分析多种类型歧视的新方法
  • 批准号:
    10330589
  • 财政年份:
    2019
  • 资助金额:
    $ 17.29万
  • 项目类别:
Advancing novel methods to measure and analyze multiple types of discrimination for population health research
为人口健康研究推进测量和分析多种类型歧视的新方法
  • 批准号:
    10551734
  • 财政年份:
    2019
  • 资助金额:
    $ 17.29万
  • 项目类别:
DNA methylation & adversity: pathways from exposures to health inequities
DNA甲基化
  • 批准号:
    9811618
  • 财政年份:
    2019
  • 资助金额:
    $ 17.29万
  • 项目类别:
DNA methylation & adversity: pathways from exposures to health inequities
DNA甲基化
  • 批准号:
    10363700
  • 财政年份:
    2019
  • 资助金额:
    $ 17.29万
  • 项目类别:
Long-term trends in breast cancer DNA copy number alterations & disparities
乳腺癌 DNA 拷贝数改变的长期趋势
  • 批准号:
    9271922
  • 财政年份:
    2016
  • 资助金额:
    $ 17.29万
  • 项目类别:
Long-Term Trends in Breast Cancer Tumor Profiles & Disparities
乳腺癌肿瘤概况的长期趋势
  • 批准号:
    8460731
  • 财政年份:
    2013
  • 资助金额:
    $ 17.29万
  • 项目类别:
Jim Crow & health disparities: exploring age-period-cohort effects
吉姆克劳
  • 批准号:
    8537876
  • 财政年份:
    2012
  • 资助金额:
    $ 17.29万
  • 项目类别:
Jim Crow & health disparities: exploring age-period-cohort effects
吉姆克劳
  • 批准号:
    8325806
  • 财政年份:
    2012
  • 资助金额:
    $ 17.29万
  • 项目类别:
EXPLORING TRENDS IN US HEALTH INEQUITIES IN CONTEXT: NHES TO NHANES, 1959-2006
探索美国健康不平等的趋势:NHES 到 NHANES,1959-2006
  • 批准号:
    8529880
  • 财政年份:
    2011
  • 资助金额:
    $ 17.29万
  • 项目类别:
EXPLORING TRENDS IN US HEALTH INEQUITIES IN CONTEXT: NHES TO NHANES, 1959-2006
探索美国健康不平等的趋势:NHES 到 NHANES,1959-2006
  • 批准号:
    8043418
  • 财政年份:
    2011
  • 资助金额:
    $ 17.29万
  • 项目类别:

相似国自然基金

无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
  • 批准号:
    62372118
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
  • 批准号:
    82300679
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
  • 批准号:
    82301784
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
  • 批准号:
    82301217
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
  • 批准号:
    82373667
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
近期流行病期间妊娠期感染后婴儿的免疫和神经系统发育
  • 批准号:
    10784250
  • 财政年份:
    2023
  • 资助金额:
    $ 17.29万
  • 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
  • 批准号:
    10794761
  • 财政年份:
    2023
  • 资助金额:
    $ 17.29万
  • 项目类别:
Mucosal immunity to sapovirus in early childhood
幼儿期对沙波病毒的粘膜免疫
  • 批准号:
    10677051
  • 财政年份:
    2023
  • 资助金额:
    $ 17.29万
  • 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
  • 批准号:
    10651082
  • 财政年份:
    2023
  • 资助金额:
    $ 17.29万
  • 项目类别:
Loss of Y-chromosome as a driver of HIV-1 latency
Y 染色体丢失是 HIV-1 潜伏期的驱动因素
  • 批准号:
    10882257
  • 财政年份:
    2023
  • 资助金额:
    $ 17.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了